Adverse Events For Generic Of GSK's Advair Diskus On US FDA’s Radar

 
• By Derrick Gingery

As patients log device complaints for Mylan’s Advair Diskus generic Wixela Inhub, the agency is assessing whether additional reminders about the products’ differences are needed.

Survelliance camera
The FDA Office of Generic Drugs does not want differences between complex generics and their reference products to hinder generic uptake. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics